23.11.2016 • News

Evonik to Expand Foam Output at Darmstadt

(c) Evonik
(c) Evonik

Evonik Resource Efficiency, an offshoot of Essen-based chemical producer Evonik, has announced it will expand capacity of its Rohacell brand foam production facility at Darmstadt, Germany by about 20%. The first expansion stage, in which new production equipment will be installed, is due on stream in the second half of 2017.  Investment costs have not been disclosed.

The plant, part of Evonik’s Performance Foams business, manufactures a rigid, structural polymethacrylimide foam used in the design and production of sandwich composites in aerospace, automotive, marine, sports equipment, electronics and medical technology. The ultra-lightweight foam also is said to withstand high temperatures and pressure.

Evonik said the expansion is in response to steady annual global growth in the use of composites as multiple industries face the challenge of developing products that are lightweight, strong and dependable in addition to being efficient to manufacture.

Matthias Kottenhahn, senior vice president of the High Performance Polymers Business Line, said the Rohacell brand has experienced double-digit growth in recent years and the company expects demand to continue positive. “With this consistent level of growth in global demand, we see this capacity expansion as a positive and necessary step toward assuring our customers of their continued access to our innovative product – now and far into the future," he added.

Alongside Darmstadt, Evonik has additional foam production locations at Mobile, Alabama, USA, and Shanghai, China, supplying customers in both North & South America and Asia respectively. 

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.